Lantern Pharma Inc. Deferred Tax Assets, Unrealized Losses on Trading Securities
Lantern Pharma Inc. (LTRN) had Deferred Tax Assets, Unrealized Losses on Trading Securities of $22.62 thousand as of 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities · last filed 2025-03-27
- 2023-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $22.62K.
- 2022-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $62.64K.
- 2021-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $26.93K.
| Period end | Deferred Tax Assets, Unrealized Losses on Trading Securities |
|---|---|
| 2023-12-31 | $22.62K 10-K · filed 2025-03-27 |
| 2022-12-31 | $62.64K 10-K · filed 2024-03-18 |
| 2021-12-31 | $26.93K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |